Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
about
Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndromeClinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case seriesHigh levels of type 2 cytokine-producing cells in chronic fatigue syndromeA Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsImmunologic abnormalities in chronic fatigue syndromeSensory and cognitive event-related potentials in myalgic encephalomyelitis.Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome.DNA methylation modifications associated with chronic fatigue syndrome.EBV Chronic InfectionsEarly events in retrovirus XMRV infection of the wild-derived mouse Mus pahari.Chronic fatigue syndrome is associated with diminished intracellular perforin.Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome).Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults.Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptorsRecognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements.Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.The chronic fatigue syndrome: a return to common senseUnperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.Psychological and immunological correlates of acute overtrainingPlasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins.The relationship between the frequency of the common cold and the activities of natural killer cells.Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Longitudinal associations of lymphocyte subsets with clinical outcomes in chronic fatigue syndrome
P2860
Q24563722-241E88B8-9BB6-4C5C-BD3E-87DABE0BD7CFQ24647924-2957F95E-C7D9-463C-A29A-6953ED7B5E07Q24684394-E8CC493D-6739-4A22-AD78-BDDEE7329AA6Q26747503-7ECB1AB0-310D-4E80-9281-63C5D80D39DAQ26998412-E46BA4BD-E401-4C08-AF1C-17C2A00FC770Q28240155-36D5FA9F-CED2-44C9-BC76-4B75700C0732Q33588751-CAC1AE3D-D4E4-4BB7-8486-A46C4FB31149Q33593176-8F5F3245-B5CA-4CC0-921C-F8A818A1FBB7Q33997492-1F446372-04EF-4839-B589-C56324FA4EC2Q34027879-5E93B4A1-5D29-471E-893A-631DB34CA823Q34171625-9EEC8DFD-540E-4397-9D40-5EBD23B57DE0Q34487834-8DC85424-AB30-4108-AA7B-CB8B29A762A4Q34546154-E20E621F-CB23-4B1A-8F81-0607E640AA01Q34560900-AC9CB73C-4BBB-4755-990D-B81624640B04Q35648873-9C266F95-9657-4FAE-9BE2-60FC6B0B696BQ36056594-1D1BA958-7D51-4D86-BF75-A37E720370B0Q36210164-E6F96820-7967-447D-BE39-1E1FB253E334Q36351101-4E2D242B-9D6A-4314-8D45-E2DB99B1CB3EQ36362289-0AC2AB51-EA99-449F-82D9-CFFB5706B27AQ36381019-F3BEE847-CE1B-48B0-AC5B-030ADF0CEDEBQ36955692-FBDB128E-F25A-4D40-AAF8-7273A72FCCD6Q37968491-B68C5509-D925-4FB5-858F-10C571881C7BQ40128256-8271C61D-3129-4125-AECB-7C470DED372FQ41305282-00579129-A047-4767-9FA9-6E75F321A137Q41852549-1A033589-9016-4338-9B8C-71922C112662Q43074822-8C72170D-71A8-44A1-8358-17F5934F51A4Q53667920-B9C22180-0B92-4531-8D32-D9F6E3AA6CA0Q55387468-5B6DB72A-FC5F-4DD6-A419-E7B86F516FB3Q57565816-DB2D4168-B305-4E64-BD40-8B00B1E48AB6
P2860
Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@ast
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@en
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@nl
type
label
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@ast
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@en
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@nl
prefLabel
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@ast
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@en
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@nl
P2093
P1476
Phenotypic and functional defi ...... with chronic fatigue syndrome.
@en
P2093
Caligiuri M
Komaroff AL
Peterson D
P304
P407
P577
1987-11-01T00:00:00Z